A new trading day began on Monday, with Edgewise Therapeutics Inc (NASDAQ: EWTX) stock price down -2.02% from the previous day of trading, before settling in for the closing price of $35.57. EWTX’s price has ranged from $5.12 to $36.66 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 5.98%. With a float of $59.21 million, this company’s outstanding shares have now reached $70.45 million.
Let’s determine the extent of company efficiency that accounts for 88 employees. In terms of profitability, gross margin is 9.41%, operating margin of -6046.8%, and the pretax margin is -5145.56%.
Edgewise Therapeutics Inc (EWTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Edgewise Therapeutics Inc is 36.86%, while institutional ownership is 71.49%. The most recent insider transaction that took place on Sep 20 ’24, was worth 2,120,101. In this transaction Chief Scientific Officer of this company sold 75,000 shares at a rate of $28.27, taking the stock ownership to the 12,719 shares. Before that another transaction happened on Sep 20 ’24, when Company’s General Counsel sold 50,000 for $28.37, making the entire transaction worth $1,418,510. This insider now owns 3,252 shares in total.
Edgewise Therapeutics Inc (EWTX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 5.98% per share during the next fiscal year.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Here are Edgewise Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 30.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.53, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.87 in one year’s time.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
Looking closely at Edgewise Therapeutics Inc (NASDAQ: EWTX), its last 5-days average volume was 1.16 million, which is a jump from its year-to-date volume of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 84.66%. Additionally, its Average True Range was 1.78.
During the past 100 days, Edgewise Therapeutics Inc’s (EWTX) raw stochastic average was set at 91.64%, which indicates a significant increase from 82.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.96% in the past 14 days, which was lower than the 93.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.49, while its 200-day Moving Average is $18.87. However, in the short run, Edgewise Therapeutics Inc’s stock first resistance to watch stands at $35.57. Second resistance stands at $36.30. The third major resistance level sits at $37.03. If the price goes on to break the first support level at $34.12, it is likely to go to the next support level at $33.39. Should the price break the second support level, the third support level stands at $32.66.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Key Stats
With a market capitalization of 3.27 billion, the company has a total of 93,399K Shares Outstanding. Currently, annual sales are 0 K while annual income is -100,160 K. The company’s previous quarter sales were 0 K while its latest quarter income was -31,500 K.
